Predicting optimal dihydroartemisinin-piperaquine regimens to prevent malaria during pregnancy for HIV-infected women receiving efavirenz.

about

Predicting optimal dihydroartemisinin-piperaquine regimens to prevent malaria during pregnancy for HIV-infected women receiving efavirenz.

Item

http://www.wikidata.org/entity/Q47258627

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Predicting optimal dihydroarte ...... ted women receiving efavirenz.

@en

Predicting optimal dihydroarte ...... ted women receiving efavirenz.

@nl

type

Item

label

Predicting optimal dihydroarte ...... ted women receiving efavirenz.

@en

Predicting optimal dihydroarte ...... ted women receiving efavirenz.

@nl

prefLabel

Predicting optimal dihydroarte ...... ted women receiving efavirenz.

@en

Predicting optimal dihydroarte ...... ted women receiving efavirenz.

@nl

P1476

Predicting optimal dihydroarte ...... ted women receiving efavirenz.

@en

P2093

Abel Kakura

http://www.w3.org/2001/XMLSchema#string

Erika Wallender

http://www.w3.org/2001/XMLSchema#string

Francesca Aweeka

http://www.w3.org/2001/XMLSchema#string

Liusheng Huang

http://www.w3.org/2001/XMLSchema#string

Mary Muhindo

http://www.w3.org/2001/XMLSchema#string

Mirium Nakalembe

http://www.w3.org/2001/XMLSchema#string

Paul Natureeba

http://www.w3.org/2001/XMLSchema#string

Prasanna Jagannathan

http://www.w3.org/2001/XMLSchema#string

Radojka M Savic

http://www.w3.org/2001/XMLSchema#string

P2860

Protective efficacy and safety of three antimalarial regimens for the prevention of malaria in young Ugandan children: a randomized controlled trial

Prediction of Improved Antimalarial Chemoprevention with Weekly Dosing of Dihydroartemisinin-Piperaquine.

Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection.

Randomized, double-blind, placebo-controlled clinical trial of a two-day regimen of dihydroartemisinin-piperaquine for malaria prevention halted for concern over prolonged corrected QT interval

Efavirenz Inhibits the Human Ether-A-Go-Go Related Current (hERG) and Induces QT Interval Prolongation in CYP2B6*6*6 Allele Carriers.

Lopinavir/ritonavir-based antiretroviral treatment (ART) versus efavirenz-based ART for the prevention of malaria among HIV-infected pregnant women

Malaria transmission, infection, and disease at three sites with varied transmission intensity in Uganda: implications for malaria control.

Efficacy and safety of three regimens for the prevention of malaria in young HIV-exposed Ugandan children: a randomized controlled trial.

The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-saharan Africa.

Rethinking Dosing Regimen Selection of Piperaquine for Malaria Chemoprevention: A Simulation Study.

P31

scholarly article

P356

10.1093/INFDIS/JIX660

http://www.w3.org/2001/XMLSchema#string

P407

English

P50

P577

2017-12-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29272443

http://www.w3.org/2001/XMLSchema#string

P921

7bèla

malaria

pregnancy-associated malaria

malaria prevention

P932

5853566

http://www.w3.org/2001/XMLSchema#string